InsiderClue
Stocks · Health care · Pharmaceutical Preparations

CORCEPT THERAPEUTICS INC

CORT Clue Score67
United States Fiscal year ends December CIK 0001088856 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

18
Insider
Date
Role
Action
Shares
Price
Amount
Gary Charles Robb
17 Sep 2026
Chief Business Officer
Exercised, kept
17,493
$8.27
$144.67K
David L Mahoney
13 Mar 2026
Director
Exercised, kept
30,000
$5.86
$175.80K
James N Wilson
24 Feb 2026
Director
Exercised, kept
100,000
$3.88
$388.00K
Hazel Hunt
9 Feb 2026
Chief Scientific Officer
Exercised, kept
150,000
$3.88
$582.00K
G Leonard Baker Jr
27 Jan 2026
Director
Exercised, kept indirect
30,000
$15.15
$454.50K
G Leonard Baker Jr
27 Jan 2026
Director
Exercised, kept indirect
25,000
$10.50
$262.50K
G Leonard Baker Jr
27 Jan 2026
Director
Exercised, kept indirect
25,000
$14.08
$352.00K
G Leonard Baker Jr
27 Jan 2026
Director
Exercised, kept indirect
30,000
$12.13
$363.90K
G Leonard Baker Jr
27 Jan 2026
Director
Exercised, kept indirect
30,000
$5.86
$175.80K
Joseph K Belanoff
24 Dec 2025
Chief Executive Officer
Exercised, kept
550,000
$3.88
$2.13M
Gary Charles Robb
24 Dec 2025
Chief Business Officer
Exercised, kept
145,000
$3.88
$562.60K
Gillian Cannon
4 Sep 2025
Director
Exercised, kept
11,000
$22.99
$252.89K
Sean Maduck
29 May 2025
See Remarks
Exercised, kept
10,000
$3.88
$38.80K
Hazel Hunt
11 Feb 2025
Chief Scientific Officer
Exercised, kept
150,000
$3.29
$493.50K
James N Wilson
22 Jan 2025
Director
Exercised, kept
250,000
$3.29
$822.50K
Gary Charles Robb
3 Jan 2025
Chief Business Officer
Exercised, kept
3,037
$3.29
$9.99K
Hazel Hunt
1 Aug 2024
Chief Scientific Officer
Exercised, kept
60,000
$2.81
$168.60K
Joseph K Belanoff
31 Jul 2024
Chief Executive Officer
Exercised, kept
450,000
$3.29
$1.48M
Showing 250 of 501 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 533
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 54
Sales straight out of an exercise 272
Sales at will 81
Transactions with no price 0
Shares from compensation/vesting 26,054,175
Sales filed before the plan box existed 65
History held since 3 Oct 2006